Hila Zelicha
Ben-Gurion University of the Negev
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hila Zelicha.
Circulation | 2017
Yftach Gepner; Ilan Shelef; Dan Schwarzfuchs; Hila Zelicha; Lilac Tene; Anat Meir; Gal Tsaban; Noa Cohen; Nitzan Bril; Michal Rein; Dana Serfaty; Shira Kenigsbuch; Oded Komy; Arik Wolak; Yoash Chassidim; Rachel Golan; Hilla Avni-Hassid; Avital Bilitzky; Benjamin Sarusi; E. Goshen; Elad Shemesh; Yaakov Henkin; Michael Stumvoll; Matthias Blüher; Joachim Thiery; Uta Ceglarek; Assaf Rudich; Meir J. Stampfer; Iris Shai
Background: We aimed to assess whether distinct lifestyle strategies can differentially affect specific body adipose depots. Methods: We performed an 18-month randomized controlled trial among 278 sedentary adults with abdominal obesity (75%) or dyslipidemia in an isolated workplace with a monitored provided lunch. Participants were randomized to isocaloric low-fat or Mediterranean/low-carbohydrate (MED/LC) diet+28 g walnuts/day with/without added moderate physical activity (PA; 80% aerobic; supervised/free gym membership). Overall primary outcome was body fat redistribution, and the main specific end point was visceral adipose tissue (VAT). We further followed the dynamics of different fat depots (deep and superficial subcutaneous, liver, pericardial, muscle, pancreas, and renal sinus) by magnetic resonance imaging. Results: Of 278 participants (age, 48 years, 89% men, body mass index, 30.8 kg/m2), 86% completed the trial with good adherence. The low-fat group preferentially decreased reported fat intake (−21.0% versus −11.5% for the MED/LC; P<0.001), and the MED/LC group decreased reported carbohydrates intake (−39.5% versus −21.3% for the low-fat group; P<0.001). The PA+ groups significantly increased the metabolic equivalents per week versus the PA− groups (19.0 versus 2.1; P=0.009). Whereas final moderate weight loss was indifferent, exercise attenuated the waist circumference rebound with the greatest effect in the MED/LCPA+ group (P<0.05). VAT (−22%), intrahepatic (−29%), and intrapericardial (−11%) fats declines were higher than pancreatic and femur intermuscular fats (1% to 2%) loss. Independent of weight loss, PA+ with either diet had a significantly greater effect on decreasing VAT (mean of difference, −6.67cm2; 95% confidence interval, −14.8 to −0.45) compared with PA−. The MED/LC diet was superior to the low-fat diet in decreasing intrahepatic, intrapericardial, and pancreatic fats (P<0.05 for all). In contrast, renal sinus and femoral intermuscular fats were not differentially altered by lifestyle interventions but by weight loss per se. In multivariate models further adjusted for weight loss, losing VAT or intrahepatic fat was independently associated with improved lipid profile, losing deep subcutaneous adipose tissue with improved insulin sensitivity, and losing superficial subcutaneous adipose tissue remained neutral except for an association with decreased leptin. Conclusions: Moderate weight loss alone inadequately reflects the significant lifestyle effects on atherogenic and diabetogenic fat depots. The MED/LC diet mobilizes specific ectopic fat depots, and exercise has an independent contribution to VAT loss. Fat depots exhibit diverse responsiveness and are differentially related to cardiometabolic markers. Distinct lifestyle protocols may uniquely induce fat mobilization from specific anatomic sites. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01530724.
The American Journal of Clinical Nutrition | 2017
Gal Tsaban; Arik Wolak; Hila Avni-Hassid; Yftach Gepner; Ilan Shelef; Yaakov Henkin; Dan Schwarzfuchs; Noa Cohen; Nitzan Bril; Michal Rein; Dana Serfaty; Shira Kenigsbuch; Lilac Tene; Hila Zelicha; Anat Yaskolka-Meir; Oded Komy; Avital Bilitzky; Yoash Chassidim; Uta Ceglarek; Michael Stumvoll; Matthias Blüher; Joachim Thiery; Dror Dicker; Assaf Rudich; Meir J. Stampfer; Iris Shai
Background: In view of evidence linking pericardial fat accumulation with increased cardiovascular disease risk, strategies to reduce its burden are needed. Data comparing the effects of specific long-term dietary interventions on pericardial fat tissue mobilization are sparse.Objective: We sought to evaluate intrapericardial-fat (IPF) and extrapericardial-fat (EPF) changes during weight-loss interventions by different dietary regimens.Design: During 18 mo of a randomized controlled trial, we compared a Mediterranean/low-carbohydrate (MED/LC) diet plus 28 g walnuts/d with a calorically equal low-fat (LF) diet among randomly assigned participants with moderate abdominal obesity. We performed whole-body MRI and volumetrically quantified IPF and EPF among 80 participants to follow the 18-mo changes.Results: The participants [mean age: 48.6 y; mean body mass index (BMI; in kg/m2); 31.7; 90% men] had baseline IPF and EPF (mean ± SD) volumes of 172.4 ± 53.3 mL and 194.9 ± 71.5 mL, respectively. The 18-mo moderate weight loss of 3.7 kg was similar in both groups, but the reduction in waist circumference was higher in the MED/LC group (-6.9 ± 6.6 cm) than in the LF diet group (-2.3 ± 6.5 cm; P = 0.01). After 18 mo, the IPF volume had reduced twice as much in the MED/LC group compared with the LF group [-37 ± 26.2 mL (-22% ± 15%) compared with -15.5 ± 26.2 mL (-8% ± 15%), respectively; P < 0.05, after adjustment for changes in weight or visceral adipose tissue]. The EPF volume had reduced similarly in both groups [-41.6 ± 30.2 mL (-23% ± 16%) in the MED/LC group compared with -37.9 ± 28.3 mL (-19% ± 14%) in the LF group; P > 0.1]. After controlling for weight loss, IPF and EPF volume reduction paralleled changes in lipid profile but not with improved glycemic profile variables: the IPF relative reduction was associated with a decrease in triglycerides (TGs) (β = 0.090; 95% CI: 0.026, 0.154; P = 0.007) and the ratio of TGs to high-density lipoprotein (HDL) cholesterol (β = 2.689; 95% CI: 0.373, 5.003; P = 0.024), and the EPF relative reduction was associated with an increase in HDL cholesterol (β = -0.452; 95% CI: -0.880, -0.023; P = 0.039) and a decrease in total cholesterol and HDL cholesterol (β = 3.766; 95% CI: 1.092, 6.440; P = 0.007).Conclusions: Moderate but persistent dietary-induced weight loss substantially decreased both IPF and EPF volumes. Reduction of pericardial adipose tissues is independently associated with an improved lipid profile. The Mediterranean diet, rich in unsaturated fats and restricted carbohydrates, is superior to an LF diet in terms of the IPF burden reduction. This trial was registered at clinicaltrials.gov as NCT01530724.
Journal of Applied Physiology | 2016
Anat Meir; Ilan Shelef; Dan Schwarzfuchs; Yftach Gepner; Lilac Tene; Hila Zelicha; Gal Tsaban; Avital Bilitzky; Oded Komy; Noa Cohen; Nitzan Bril; Michal Rein; Dana Serfaty; Shira Kenigsbuch; Yoash Chassidim; Lior Zeller; Uta Ceglarek; Michael Stumvoll; Matthias Blüher; Joachim Thiery; Meir J. Stampfer; Assaf Rudich; Iris Shai
It remains unclear whether intermuscular adipose tissue (IMAT) has any metabolic influence or whether it is merely a marker of abnormalities, as well as what are the effects of specific lifestyle strategies for weight loss on the dynamics of both IMAT and thigh muscle area (TMA). We followed the trajectory of IMAT and TMA during 18-mo lifestyle intervention among 278 sedentary participants with abdominal obesity, using magnetic resonance imaging. We measured the resting metabolic rate (RMR) by an indirect calorimeter. Among 273 eligible participants (47.8 ± 9.3 yr of age), the mean IMAT was 9.6 ± 4.6 cm(2) Baseline IMAT levels were directly correlated with waist circumference, abdominal subdepots, C-reactive protein, and leptin and inversely correlated with baseline TMA and creatinine (P < 0.05 for all). After 18 mo (86.3% adherence), both IMAT (-1.6%) and TMA (-3.3%) significantly decreased (P < 0.01 vs. baseline). The changes in both IMAT and TMA were similar across the lifestyle intervention groups and directly corresponded with moderate weight loss (P < 0.001). IMAT change did not remain independently associated with decreased abdominal subdepots or improved cardiometabolic parameters after adjustments for age, sex, and 18-mo weight loss. In similar models, 18-mo TMA loss remained associated with decreased RMR, decreased activity, and with increased fasting glucose levels and IMAT (P < 0.05 for all). Unlike other fat depots, IMAT may not represent a unique or specific adipose tissue, instead largely reflecting body weight change per se. Moderate weight loss induced a significant decrease in thigh muscle area, suggesting the importance of resistance training to accompany weight loss programs.
Diabetes-metabolism Research and Reviews | 2017
Anat Meir; Lilac Tene; Noa Cohen; Ilan Shelef; Dan Schwarzfuchs; Yftach Gepner; Hila Zelicha; Michal Rein; Nitzan Bril; Dana Serfaty; Shira Kenigsbuch; Yoash Chassidim; Benjamin Sarusy; Dror Dicker; Joachim Thiery; Uta Ceglarek; Michael Stumvoll; Matthias Blüher; Meir J. Stampfer; Assaf Rudich; Iris Shai
Intrahepatic fat (IHF) is best known to associate with waist circumference (WC) and visceral adipose tissue (VAT), but its relation to abdominal subcutaneous adipose tissue is controversial. While IHF ≥ 5% dichotomously defines fatty liver, %IHF is rarely considered as a continuous variable that includes the normal range. In this study, we aimed to evaluate %IHF association with abdominal fat subdepots, pancreatic, and renal‐sinus fats.
PLOS ONE | 2017
Yftach Gepner; Ilan Shelef; Dan Schwarzfuchs; Noa Cohen; Nitzan Bril; Michal Rein; Gal Tsaban; Hila Zelicha; Anat Meir; Lilac Tene; Benjamin Sarusy; Philip Rosen; Jay R. Hoffman; Jeffrey R. Stout; Joachim Thiery; Uta Ceglarek; Michael Stumvoll; Matthias Blüher; Meir J. Stampfer; Iris Shai; Gordon Fisher
Background Intramyocellular triacylglycerol (IMTG) is utilized as metabolic fuel during exercise and is linked to insulin resistance, but the long-term effect of weight loss strategies on IMTG among participants with abdominal fat, remain unclear. Methods In an 18-month trial, sedentary participants with abdominal fat/dyslipidemia were randomized to either a low-fat (LF) or Mediterranean/low-carbohydrate (MED/LC) diet (including 28g·day-1 of walnuts). After 6-months, the participants were re-randomized to moderate intense physical activity (PA+) or non-physical activity (PA-). Magnetic resonance imaging (MRI) was used to quantify changes of IMTG, abdominal sub-depots, hepatic and intermuscular fats. Results Across the 277 participants [86% men, age = 48 years, body-mass-index (BMI) = 31kg/m2, visceral fat = 33%] 86% completed the 18-m trial. At baseline, women had higher IMTG than men (3.4% vs. 2.3%, p<0.001) and increased IMTG was associated with aging and higher BMI, visceral and intermuscular fats, HbA1c%, HDL-c and leptin(p<0.05), but not with intra-hepatic fat. After 18 month of intervention and a -3 kg mean weight loss, participants significantly increased IMTG by 25%, with a distinct effect in the MED/LCPA+ group as compared to the other intervention groups (57% vs. 9.5–18.5%, p<0.05). Changes in IMTG were associated with visceral and intermuscular fat, metabolic syndrome, insulin and leptin (p<0.05 for all), however, these associations did not remain after adjustment for visceral fat changes. Conclusions Lifestyle strategies differentially affect IMTG accumulation; combination of exercise with decreased carbohydrate/increased unsaturated fat proportion intake greatly increase IMTG. Our findings suggest that increased IMTG during diet-induced moderate weight loss may not be directly related to cardiometabolic risk. Trial registration ClinicalTrials.gov NCT01530724
Journal of Applied Physiology | 2017
Yftach Gepner; Jay R. Hoffman; Elad Shemesh; Jeffrey R. Stout; David D. Church; Alyssa N. Varanoske; Hila Zelicha; Ilan Shelef; Yacov Chen; Hagai Frankel; Ishay Ostfeld
The purpose of this study was to compare the coadministration of the probiotic Bacillus coagulans GBI-30, 6086 (BC30) with β-hydroxy-β-methylbutyrate (HMB) calcium (CaHMB) to CaHMB alone on inflammatory response and muscle integrity during 40 days of intense military training. Soldiers were randomly assigned to one of two groups: CaHMB with BC30 (CaHMBBC30; n = 9) or CaHMB with placebo (CaHMBPL, n = 9). A third group of participants served as a control (CTL; n = 8). During the first 28 days soldiers were garrisoned on base and participated in the same training tasks. During the final 2 wk soldiers navigated 25-30 km per night in difficult terrain carrying ~35 kg of equipment. All assessments (blood draws and diffusion tensor imaging to assess muscle integrity) were conducted before and ~12 h after final supplement consumption. Analysis of covariance was used to analyze all blood and muscle measures. Significant attenuations were noted in IL-1β, IL-2, IL-6, CX3CL1, and TNF-α for both CaHMBBC30 and CaHMBPL compared with CTL. Plasma IL-10 concentrations were significantly attenuated for CaHMBBC30 compared with CTL only. A significant decrease in apparent diffusion coefficients was also observed for CaHMBBC30 compared with CaHMBPL. Results provide further evidence that HMB supplementation may attenuate the inflammatory response to intense training and that the combination of the probiotic BC30 with CaHMB may be more beneficial than CaHMB alone in maintaining muscle integrity during intense military training.NEW & NOTEWORTHY β-Hydroxy-β-methylbutyrate (HMB) in its free acid form was reported to attenuate inflammation and maintain muscle integrity during military training. However, this formulation was difficult to maintain in the field. In this investigation, soldiers ingested HMB calcium (CaHMB) with Bacillus coagulans (BC30) or CaHMB alone during 40 days of training. Results indicated that CaHMB attenuated the inflammatory response and that BC30 combined with CaHMB may be more beneficial than CaHMB alone in maintaining muscle integrity during intense military training.
Clinical Nutrition | 2017
Hila Zelicha; Dan Schwarzfuchs; Ilan Shelef; Yftach Gepner; Gal Tsaban; Lilac Tene; Anat Meir; Avital Bilitzky; Oded Komy; Noa Cohen; Nitzan Bril; Michal Rein; Dana Serfaty; Shira Kenigsbuch; Yoash Chassidim; Benjamin Sarusi; Joachim Thiery; Uta Ceglarek; Michael Stumvoll; Matthias Blüher; Yosef S. Haviv; Meir J. Stampfer; Assaf Rudich; Iris Shai
Journal of Strength and Conditioning Research | 2018
Jay R. Hoffman; Yftach Gepner; Mattan W. Hoffman; Hila Zelicha; Shachar Shapira; Ishay Ostfeld
Clinical nutrition ESPEN | 2018
Lilac Tene; Ilan Shelef; Dan Schwarzfuchs; Yftach Gepner; Anat Meir; Gal Tsaban; Hila Zelicha; Avital Bilitzky; Oded Komy; Noa Cohen; Nitzan Bril; Michal Rein; Dana Serfaty; Shira Kenigsbuch; Yoash Chassidim; Benjamin Sarusy; Uta Ceglarek; Michael Stumvoll; Matthias Blüher; Joachim Thiery; Meir J. Stampfer; Assaf Rudich; Iris Shai
Circulation | 2018
Yftach Gepner; Ilan Shelef; Dan Schwarzfuchs; Hila Zelicha; Lilac Tene; Anat Meir; Gal Tsaban; Noa Cohen; Nitzan Bril; Michal Rein; Dana Serfaty; Shira Kenigsbuch; Oded Komy; Arik Wolak; Yoash Chassidim; Rachel Golan; Hila Avni-Hassid; Avital Bilitzky; Benjamin Sarusi; E. Goshen; Elad Shemesh; Yaakov Henkin; Michael Stumvoll; Matthias Blüher; Joachim Thiery; Uta Ceglarek; Assaf Rudich; Meir J. Stampfer; Iris Shai